ProQR Therapeutics N.V. - Ordinary Shares (PRQR) Social Stream



ProQR Therapeutics N.V. - Ordinary Shares (PRQR): $0.86

0.04 (+5.51%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add PRQR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 401

in industry

ProQR Therapeutics NV (PRQR) Price Targets From Analysts

Use the tables below to see what analysts covering ProQR Therapeutics NV think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-28 4 $33 $18 $22.75 $0.98 2221.43%
2022-01-31 5 $33 $18 $22 $0.98 2144.9%
2022-02-14 6 $18 $1.7 $6.74 $0.98 587.76%
2022-02-28 6 $8 $1.7 $4.54 $0.98 363.27%

The Trend in the Analyst Price Target


Over the past 16 months, PRQR's average price target has gone down $13.83.

Over the past 46 weeks, PRQR's average upside potential has been 311.62%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-15 7 45.08605 18.44434 26.63697 6.18 331.02%
2021-05-27 7 43.14372 17.64975 25.61272 6.00 326.88%
2021-05-27 7 43.76800 17.90514 25.98334 6.00 333.06%
2021-08-24 7 37.53175 17.24432 25.69276 6.39 302.08%
2021-08-24 7 37.00597 17.00275 25.33284 6.39 296.45%

PRQR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 3 0 3 0 0 6

The Trend in the Broker Recommendations


Over the past 31 days, PRQR's average broker recommendation rating worsened by 0.6.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • ProQR Therapeutics NV's upside potential (average analyst target price relative to current price) is greater than 586.13% of all US stocks.
  • In terms of how ProQR Therapeutics NV fares relative to all US stocks, note that its variance in analysts' estimates is lower than -433.13% of that group.
  • In terms of how ProQR Therapeutics NV fares relative to Healthcare stocks, note that its average analyst price target is greater than 130.41% of that group.
  • ProQR Therapeutics NV's number of analysts covering the stock is higher than 419.7% of stocks in the small market cap category.

Stocks similar to ProQR Therapeutics NV in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PROC, PRDS, and PPBT.

What is the outlook for PRQR? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5167 seconds.